Competition between low-dose aspirin and other NSAIDs for COX-1 binding and its clinical consequences for the drugs' antiplatelet effects.
about
Competition between low-dose aspirin and other NSAIDs for COX-1 binding and its clinical consequences for the drugs' antiplatelet effects.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Competition between low-dose a ...... e drugs' antiplatelet effects.
@en
type
label
Competition between low-dose a ...... e drugs' antiplatelet effects.
@en
prefLabel
Competition between low-dose a ...... e drugs' antiplatelet effects.
@en
P2860
P1476
Competition between low-dose a ...... e drugs' antiplatelet effects.
@en
P2093
Gilad Rimon
P2860
P356
10.1517/17425255.2014.971010
P407
P577
2014-10-13T00:00:00Z